FORT LAUDERDALE, Fla.— At the American Glaucoma Society meeting, Robert Noecker, MD, of Ophthalmic Consultants of Connecticut, discusses the many uses of Ocular Therapeutix products in glaucoma therapy.
Author: Healio ophthalmology
VIDEO: Update on management of patients with corneal endothelial disease
At OSN New York, Thomas John, MD, discusses various corneal transplantation options for patients with corneal endothelial disease.
VIDEO: Strategies for small pupils
At OSN New York, John A. Hovanesian, MD, FACS, gives pearls on managing patients with small pupils.
VIDEO: Enhancement techniques for premium IOLs
At OSN New York, Alan R. Faulkner, MD, shares pearls for enhancement techniques for premium IOL patients.
Iris cysts may be associated with dissecting aortic aneurysms
PHILADELPHIA — A type of congenital iris cyst may be associated with life-threatening dissecting aortic aneurysms, a speaker said at the Wills Eye Alumni Conference here.Bilateral multifocal iris pigment epithelial cysts, also known as iris flocculi, may result from a shared genetic mutation in smooth muscle that affects the iris and aorta, Jerry A. Shields, MD, said.
FDA warns public about loose plastic safety seals on eye drop bottles
The FDA is warning the public about eye drop bottles that have loose plastic safety seals or tamper evident rings below the bottle cap, according to a press release from the FDA. Some eye drop bottles are losing the safety seals or rings when consumers…
Victor T. Curtin, MD, long-time professor at Bascom Palmer, dies
Victor T. Curtin, MD, professor emeritus of ophthalmology at Bascom Palmer Eye Institute, died March 9 in Miami. Curtin was the first faculty member recruited for Bascom Palmer Eye Institute, University of Miami School of Medicine, where he serve…
iStent reduces IOP with no postop medication through 18 months
FORT LAUDERDALE, Fla. — A second-generation ab interno stent reduced IOP to less than 15 mm Hg without postoperative medication through 18 months in patients with open-angle glaucoma, according to a scientific poster presented here. Richard A. Lewis, MD, reported study results on behalf of the MIGS Study Group at the American Glaucoma Society meeting.
Aggressive intervention minimizes sight-threatening potential of periorbital necrotizing fasciitis
PHILADELPHIA — Early identification, immediate and aggressive surgical intervention, and application of both systemic and postoperative topical clindamycin can be sight-saving in cases of periorbital necrotizing fasciitis, according to a presentation here.“Necrotizing fasciitis of the periorbital region is an exceedingly rare condition, with less than 100 cases reported over the past 20 years,” Charles Kim, MD, said at the Wills Eye Alumni Conference “To put it in further perspective, the two largest case series to date consist of 17 and seven patients, respectively, so the span of five, our project, (Read more...)
Trabectome-phaco yields less refractive precision than phaco alone
FORT LAUDERDALE, Fla. — Combined Trabectome surgery and phacoemulsification yielded unforeseen refractive changes that were not predicted by current IOL calculation techniques, according to a scientific poster presented here.The retrospective study, presented by Douglas J. Rhee, MD, and colleagues at the American Glaucoma Society meeting, included 50 patients with primary open-angle glaucoma; 34 patients underwent combined phacoemulsification and Trabectome (NeoMedix) surgery, and 16 patients underwent phacoemulsification alone.
Aerie reports $74.4 million net loss in 2015
Aerie Pharmaceuticals reported a GAAP net loss of $74.4 million, or $2.88 per share, in 2015, according to a company press release. In 2014, the GAAP net loss was $48.1 million, or $2 per share.
Micro-stent combined with phaco reduces IOP, medication use at 3 years
FORT LAUDERDALE, Fla. — A supraciliary micro-stent reduced IOP with a high safety profile in patients with open-angle glaucoma, according to a scientific poster presented at the American Glaucoma Society meeting here. Reay H. Brown, MD, and colleagues reported results of the CyPass Clinical Experience study, a prospective, multicenter analysis that included 522 patients; 269 patients underwent combined small-incision cataract surgery and implantation of a CyPass micro-stent (Transcend Medical). Of the 269 patients who had combined surgery, 102 had uncontrolled IOP (21 mm Hg or higher) and 167 had controlled (Read more...)
Study: Jetrea releases vitreomacular traction in majority of eyes
PHILADELPHIA – Jetrea injection resulted in vitreomacular traction release in more than half of cases, a speaker here said, relating the Wills Eye experience with the treatment.The presentation won the James S. Shipman Award for best paper during the Wills Eye Alumni Conference paper session.
Study: Bimatoprost sustained-release implant maintains IOP lowering up to 24 weeks
FORT LAUDERDALE, Fla. — At all dose strengths, a bimatoprost sustained-release implant was well tolerated and comparable to topical bimatoprost in overall IOP reduction, according to 6-month interim results of a phase 1/2 study.“We need something better than eye drops, so we’re all looking for that right way to lower pressure with a sustained delivery device,” E. Randy Craven, MD, said at the American Glaucoma Society meeting.
Epimacular brachytherapy with anti-VEGF not superior to anti-VEGF monotherapy for wet AMD
Macular epiretinal brachytherapy combined with ranibizumab did not reduce the number of ranibizumab injections that patients required for the treatment of neovascular age-related macular degeneration, according to a study.Principal investigator Tim Jac…
Breaking down the sham of statistical significance
Thomas Bayes died in 1761, but his theorem lives on and is inspiring a new generation of statistical thinking. Whether you are frequentist or Bayesian, Jack S. Parker, MD, shares a compelling argument for us to ditch the P
OCT angiography a promising imaging modality for evaluation of microvasculopathy
OCT angiography, or OCT-A, was recently developed to provide three-dimensional noninvasive viewing of the retinal and choroidal vasculature and blood flow estimation at the microcirculation level. OCT-A is based on mapping erythrocyte movement over tim…
Rho kinase inhibitor non-inferior to timolol in two phase 3 studies
FORT LAUDERDALE, Fla. — A small-molecule Rho kinase inhibitor and norepinephrine transporter was non-inferior to timolol in two clinical studies, according to a scientific poster presented here. Jason Bacharach, MD, presented results of the phase 3 ROCKET 1 and ROCKET 2 studies at the American Glaucoma Society meeting.
VIDEO: Landscape of glaucoma treatment in transition
FORT LAUDERDALE, Fla.— At the American Glaucoma Society meeting, OSN Glaucoma Board Member Savak “Sev” Teymoorian, MD, MBA, describes the changing landscape of glaucoma treatment, involving new classes of pharmaceuticals, new ways to deliver treatment and new minimally invasive glaucoma surgery devices.
VIDEO: AGS attendees offered wide range of learning opportunities
FORT LAUDERDALE, Fla. — At the American Glaucoma Society meeting, OSN Glaucoma Section Editor Thomas W. Samuelson, MD, gives an overview of the meeting’s learning opportunities, ranging widely from basic science to advanced innovative surgery techniques for lowering IOP.